Devonian Health Group Inc. (TSXV: GSD)
Canada flag Canada · Delayed Price · Currency is CAD
0.190
+0.005 (2.70%)
Dec 19, 2024, 3:36 PM EST

Devonian Health Group Statistics

Total Valuation

Devonian Health Group has a market cap or net worth of CAD 28.16 million. The enterprise value is 20.55 million.

Market Cap 28.16M
Enterprise Value 20.55M

Important Dates

The last earnings date was Thursday, December 19, 2024.

Earnings Date Dec 19, 2024
Ex-Dividend Date n/a

Share Statistics

Devonian Health Group has 148.22 million shares outstanding. The number of shares has increased by 8.51% in one year.

Current Share Class n/a
Shares Outstanding 148.22M
Shares Change (YoY) +8.51%
Shares Change (QoQ) +1.02%
Owned by Insiders (%) 0.83%
Owned by Institutions (%) n/a
Float 127.02M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.57
PB Ratio 1.95
P/TBV Ratio 6.01
P/FCF Ratio 5.00
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -16.78
EV / Sales 1.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 3.65

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.16.

Current Ratio 1.14
Quick Ratio 1.11
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF 0.40
Interest Coverage -2.26

Financial Efficiency

Return on equity (ROE) is -8.53% and return on invested capital (ROIC) is -3.10%.

Return on Equity (ROE) -8.53%
Return on Assets (ROA) -2.15%
Return on Capital (ROIC) -3.10%
Revenue Per Employee 2.55M
Profits Per Employee -174,948
Employee Count 8
Asset Turnover 0.71
Inventory Turnover 107.18

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.45% in the last 52 weeks. The beta is 1.38, so Devonian Health Group's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change -22.45%
50-Day Moving Average 0.17
200-Day Moving Average 0.18
Relative Strength Index (RSI) 50.15
Average Volume (20 Days) 21,610

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Devonian Health Group had revenue of CAD 17.82 million and -1.22 million in losses. Loss per share was -0.01.

Revenue 17.82M
Gross Profit 5.99M
Operating Income -858,442
Pretax Income -1.22M
Net Income -1.22M
EBITDA -221,368
EBIT -858,442
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 9.86 million in cash and 2.25 million in debt, giving a net cash position of 7.62 million or 0.05 per share.

Cash & Cash Equivalents 9.86M
Total Debt 2.25M
Net Cash 7.62M
Net Cash Per Share 0.05
Equity (Book Value) 14.46M
Book Value Per Share 0.10
Working Capital 2.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.63 million and capital expenditures -4,247, giving a free cash flow of 5.63 million.

Operating Cash Flow 5.63M
Capital Expenditures -4,247
Free Cash Flow 5.63M
FCF Per Share 0.04
Full Cash Flow Statement

Margins

Gross margin is 33.62%, with operating and profit margins of -4.82% and -6.87%.

Gross Margin 33.62%
Operating Margin -4.82%
Pretax Margin -6.87%
Profit Margin -6.87%
EBITDA Margin -1.24%
EBIT Margin -4.82%
FCF Margin 31.60%

Dividends & Yields

Devonian Health Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.51%
Shareholder Yield -8.51%
Earnings Yield -4.38%
FCF Yield 19.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Devonian Health Group has an Altman Z-Score of 0.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.35
Piotroski F-Score n/a